An Important Proof of Principle for the “Combination Therapy” Approach to Treating the Most Common Cystic Fibrosis Mutation

Combination of existing small molecule drug treatment of mutated proteins may lead to new therapies for patients with the most common type of cystic fibrosis.

Source: NIDDK News - March 15, 2018 Category: Endocrinology Source Type: news